Sign inJoin waitlistJoin the waitlist

Maria Bell

Physician · Sanford USD Medical Center Sioux Falls

Credentials: · · · · · · · ·

History

Sanford USD Medical Center Sioux Falls · Sanford Medical Center Fargo · Sanford Health - Bismarck
Present

Hospice and Palliative Medicine
2023–2024
Obstetrics and Gynecology
LSU Health Sciences Center
2019–2023
Gynecologic Oncology
University of Alabama Hospital
1992–1995
Obstetrics and Gynecology
University of Chicago Medical Center
1989–1992
Transitional Year
Ascension Illinois
1988–1989
University of South Dakota Sanford School of Medicine
1984–1988

Research

Comparison of outcomes and cost for endometrial cancer staging via traditional laparotomy, standard laparoscopy and robotic techniques
Gynecologic Oncology · 2008 · First of 5 authors · Corresponding · 275 citations
Lymphatic mapping and sentinel lymph node biopsy in women with squamous cell carcinoma of the vulva: a gynecologic oncology group study
Journal of Clinical Oncology · 2012 · 274 citations
Cervical cancer prevention: new tools and old barriers
Review · Cancer · 2010 · 229 citations

Federico Ampil
7 papers
Edward Partridge
5 papers
Robert Edwards
5 papers · 5 as a fellow
Ronald Alvarez
5 papers
Dedra Buchwald
3 papers
Linda Van Le
3 papers
Angeles Secord
2 papers
Anthony Restaino
2 papers
Bamidele Adesunloye
2 papers
Bhavana Pothuri
2 papers
CL
Charles Levenback
2 papers
CT
Cornelia Trimble
2 papers

Clinical trials

the Effectiveness of a Weight Management Program in Patients Who Have Completed Treatment for Endometrial Cancer
Principal investigator · Completed
Sanford Health
2019–2021
Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer
Site PI · Recruiting · Phase 3
Imunon
2025–2032
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Site PI · Recruiting · Phase 3
NRG Oncology
2025–2034
Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma
Site PI · Recruiting · Phase 3
National Cancer Institute (NCI)
2022–2027